Genetic manipulation of pathway regulation for overproduction of angucycline-like antibiotic auricin in Streptomyces aureofaciens CCM 3239
被引:0
|
作者:
Renata Novakova
论文数: 0引用数: 0
h-index: 0
机构:Institute of Molecular Biology,
Renata Novakova
Alena Rehakova
论文数: 0引用数: 0
h-index: 0
机构:Institute of Molecular Biology,
Alena Rehakova
Lubomira Feckova
论文数: 0引用数: 0
h-index: 0
机构:Institute of Molecular Biology,
Lubomira Feckova
Peter Kutas
论文数: 0引用数: 0
h-index: 0
机构:Institute of Molecular Biology,
Peter Kutas
Renata Knischova
论文数: 0引用数: 0
h-index: 0
机构:Institute of Molecular Biology,
Renata Knischova
Jan Kormanec
论文数: 0引用数: 0
h-index: 0
机构:Institute of Molecular Biology,
Jan Kormanec
机构:
[1] Institute of Molecular Biology,
[2] Slovak Academy of Sciences,undefined
来源:
Folia Microbiologica
|
2011年
/
56卷
关键词:
Streptomyces;
Direct Binding;
Polyketide;
Strict Regulation;
Bioactive Secondary Metabolite;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
The polyketide gene cluster aur1 is responsible for the production of the antibiotic auricin in Streptomyces aureofaciens CCM 3239. Auricin production is low and strictly regulated by two regulators, Aur1P and Aur1R. To improve auricin yield, we genetically manipulated S. aureofaciens CCM 3239 strain to overcome this strict regulation. A regulatory region including aur1R, aur1P, aur1O and the target biosynthetic aur1Ap promoter were replaced by the strong constitutive ermEp* promoter. However, auricin production was decreased in such a genetically manipulated strain. In the second strategy we placed the aur1P gene for auricin pathway-specific activator under the control of the ermEp* promoter. The resulting strain has been shown to produce 2.8-fold higher amount of auricin compared with the WT strain.